| scholarly article | Q13442814 |
| P2093 | author name string | Eng H Lo | |
| Xiaoying Wang | |||
| Xiang Fan | |||
| P2860 | cites work | Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke | Q28569418 |
| Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke | Q33387740 | ||
| A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes | Q34066733 | ||
| Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. | Q34171180 | ||
| Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling | Q34410352 | ||
| Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats | Q34579572 | ||
| Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. | Q34696376 | ||
| Prospects for minocycline neuroprotection | Q35079515 | ||
| Brain inflammation is induced by co-morbidities and risk factors for stroke | Q35132428 | ||
| Minocycline development for acute ischemic stroke | Q35202559 | ||
| Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke | Q35202882 | ||
| Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage | Q35581074 | ||
| Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke | Q35905986 | ||
| The promise of minocycline in neurology. | Q35958974 | ||
| Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production | Q36010304 | ||
| A rat model of focal embolic cerebral ischemia | Q36889748 | ||
| Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats | Q37017515 | ||
| Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis | Q37139530 | ||
| Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia | Q37230709 | ||
| Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy | Q37232887 | ||
| Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential | Q37367536 | ||
| Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications | Q37512877 | ||
| Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study | Q37562665 | ||
| Clinical pharmacokinetics of doxycycline and minocycline | Q39571569 | ||
| Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. | Q39932002 | ||
| Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
| Extension of the thrombolytic time window with minocycline in experimental stroke. | Q41812595 | ||
| Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline | Q41847547 | ||
| MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia | Q42413334 | ||
| Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. | Q44472506 | ||
| Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. | Q44647403 | ||
| Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. | Q45096508 | ||
| Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice | Q45240483 | ||
| Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia | Q46253405 | ||
| Role of matrix metalloproteinases in delayed cortical responses after stroke | Q48604373 | ||
| Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group | Q73877940 | ||
| Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms | Q84016180 | ||
| Exaggerated neutrophil-mediated reperfusion injury after ischemic stroke in a rodent model of type 2 diabetes | Q84431634 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | minocycline | Q415336 |
| plasminogen | Q107129060 | ||
| embolic stroke | Q107538662 | ||
| P304 | page(s) | 745-752 | |
| P577 | publication date | 2013-02-19 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats | |
| P478 | volume | 44 |
| Q50602045 | Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats. |
| Q41314097 | Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke |
| Q64996474 | Antibiotic Class and Outcome in Post-stroke Infections: An Individual Participant Data Pooled Analysis of VISTA-Acute. |
| Q40143778 | Autophagy Promotes Microglia Activation Through Beclin-1-Atg5 Pathway in Intracerebral Hemorrhage |
| Q99238065 | Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders |
| Q38688253 | Clot injection technique affects thrombolytic efficacy in a rat embolic stroke model: implications for translaboratory collaborations. |
| Q35587581 | Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. |
| Q52691666 | Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke. |
| Q90409417 | Glia-immune interactions post-ischemic stroke and potential therapies |
| Q37559355 | Hemorrhagic transformation after ischemic stroke in animals and humans |
| Q89495697 | Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness |
| Q33954912 | Hyperglycemia, acute ischemic stroke, and thrombolytic therapy |
| Q30899226 | Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. |
| Q38793026 | Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes |
| Q36976259 | Intracranial aneurysm formation in type-one diabetes rats |
| Q36614594 | Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke |
| Q38776714 | Minocycline Promotes Neurite Outgrowth of PC12 Cells Exposed to Oxygen-Glucose Deprivation and Reoxygenation Through Regulation of MLCP/MLC Signaling Pathways |
| Q89284017 | Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials |
| Q37568882 | Mmp-9 inhibition: a therapeutic strategy in ischemic stroke |
| Q37571562 | Neuroprotection in stroke: past, present, and future |
| Q37668019 | One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke |
| Q33581243 | Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice |
| Q39179831 | Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia |
| Q37193054 | Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain |
| Q35187936 | Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia. |
| Q88670464 | Targeting Reperfusion Injury in the Age of Mechanical Thrombectomy |
| Q36267227 | Targeting neutrophils in ischemic stroke: translational insights from experimental studies. |
| Q89209485 | Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches |
| Q35154166 | The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial |
| Q64951216 | tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use? |
| Q37366918 | von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage |
Search more.